Susan Webb, Hospital de Sant Pau, Spain

Review of a database established in 1997 has provided usual insights into changes and advancements in acromegaly treatment patterns in Spain over the last three decades. It found that, not surprisingly, the use of radiation therapy and dopamine agonists has decreased dramatically, whereas use of somatostatin analogues and pegvisomant has increased. Surgical rates have been maintained and is still the mainstay of treatment. There has been a steady improvement in patient outcomes, with disease now controlled in over 70% of patients.